Beijing Beilu Pharmaceutical Co.,Ltd — Investor Relations & Filings
Beijing Beilu Pharmaceutical Co.,Ltd. specializes in the research, development, production, and distribution of specialized pharmaceutical products. The company is a leading provider of contrast media, offering a comprehensive range of diagnostic imaging agents for magnetic resonance imaging (MRI) and computed tomography (CT) scans, including Gadopentetate Dimeglumine, Iohexol, and Iodixanol. Beyond its core diagnostic portfolio, the firm develops and markets treatments for central nervous system disorders, notably its proprietary Jiuwei Zhenxin Granules for the treatment of generalized anxiety disorder. Its product lineup also extends to metabolic health, featuring medications such as Repaglinide for the management of type 2 diabetes. The company focuses on technological innovation and stringent quality standards to serve clinical needs in diagnostic medicine and specialized therapeutic areas.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度会计师事务所履职情况评估报告 | 2026-04-21 | Chinese | |
| 董事会审计委员会对会计师事务所2025年度履行监督职责情况的报告 | 2026-04-21 | Chinese | |
| 2025年年度审计报告 | 2026-04-21 | Chinese | |
| 2025年年度报告摘要 | 2026-04-21 | Chinese | |
| 2025年度独立董事述职报告（曹纲） | 2026-04-21 | Chinese | |
| 董事、高级管理人员薪酬管理制度 | 2026-04-21 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 34751480 | 2025年度会计师事务所履职情况评估报告 | 2026-04-21 | Chinese | ||
| 34751469 | 董事会审计委员会对会计师事务所2025年度履行监督职责情况的报告 | 2026-04-21 | Chinese | ||
| 34751459 | 2025年年度审计报告 | 2026-04-21 | Chinese | ||
| 34751425 | 2025年年度报告摘要 | 2026-04-21 | Chinese | ||
| 34751413 | 2025年度独立董事述职报告（曹纲） | 2026-04-21 | Chinese | ||
| 34751400 | 董事、高级管理人员薪酬管理制度 | 2026-04-21 | Chinese | ||
| 34751384 | 中信建投证券股份有限公司关于北京北陆药业股份有限公司2025年度募集资金存放、管理和使用情况的专项核查报告 | 2026-04-21 | Chinese | ||
| 34751377 | 董事会关于募集资金2025年度存放、管理与使用情况的专项报告 | 2026-04-21 | Chinese | ||
| 34751342 | 2025年年度报告 | 2026-04-21 | Chinese | ||
| 34751291 | 关于召开2025年度网上业绩说明会的公告 | 2026-04-21 | Chinese | ||
| 34751271 | 2025年度社会责任报告 | 2026-04-21 | Chinese | ||
| 34751230 | 2025年度内部控制自我评价报告 | 2026-04-21 | Chinese | ||
| 34751222 | 第九届董事会第九次会议决议公告 | 2026-04-21 | Chinese | ||
| 34751213 | 2025年度独立董事述职报告（郑斌） | 2026-04-21 | Chinese | ||
| 34751203 | 关于增补非独立董事的公告 | 2026-04-21 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Beijing Beilu Pharmaceutical Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55041/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55041 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55041 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55041 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55041}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Beijing Beilu Pharmaceutical Co.,Ltd (id: 55041)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.